Liu, J., Sills, E.S., Yang, Z., Salem, S.A., Rahil, T., Collins, G.S., Liu, X. and Salem, R.D. 2012. Array comparative genomic hybridization screening in IVF significantly reduces number of embryos available for cryopreservation. Clinical & Experimental Reproductive Medicine. 39 (2), pp. 52-57. https://doi.org/10.5653/cerm.2012.39.2.52
| Title | Array comparative genomic hybridization screening in IVF significantly reduces number of embryos available for cryopreservation |
|---|---|
| Authors | Liu, J., Sills, E.S., Yang, Z., Salem, S.A., Rahil, T., Collins, G.S., Liu, X. and Salem, R.D. |
| Abstract | Objective During IVF, non-transferred embryos are usually selected for cryopreservation on the basis of morphological criteria. This investigation evaluated an application for array comparative genomic hybridization (aCGH) in assessment of surplus embryos prior to cryopreservation. Methods First-time IVF patients undergoing elective single embryo transfer and having at least one extra non-transferred embryo suitable for cryopreservation were offered enrollment in the study. Patients were randomized into two groups: Patients in group A (n=55) had embryos assessed first by morphology and then by aCGH, performed on cells obtained from trophectoderm biopsy on post-fertilization day 5. Only euploid embryos were designated for cryopreservation. Patients in group B (n=48) had embryos assessed by morphology alone, with only good morphology embryos considered suitable for cryopreservation. Results Among biopsied embryos in group A (n=425), euploidy was confirmed in 226 (53.1%). After fresh single embryo transfer, 64 (28.3%) surplus euploid embryos were cryopreserved for 51 patients (92.7%). In group B, 389 good morphology blastocysts were identified and a single top quality blastocyst was selected for fresh transfer. All group B patients (48/48) had at least one blastocyst remaining for cryopreservation. A total of 157 (40.4%) blastocysts were frozen in this group, a significantly larger proportion than was cryopreserved in group A (p=0.017, by chi-squared analysis). Conclusion While aCGH and subsequent frozen embryo transfer are currently used to screen embryos, this is the first investigation to quantify the impact of aCGH specifically on embryo cryopreservation. Incorporation of aCGH screening significantly reduced the total number of cryopreserved blastocysts compared to when suitability for freezing was determined by morphology only. IVF patients should be counseled that the benefits of aCGH screening will likely come at the cost of sharply limiting the number of surplus embryos available for cryopreservation. |
| Journal | Clinical & Experimental Reproductive Medicine |
| Journal citation | 39 (2), pp. 52-57 |
| ISSN | 2233-8233 |
| Year | Jun 2012 |
| Publisher | Korean Society for Reproductive Medicine |
| Digital Object Identifier (DOI) | https://doi.org/10.5653/cerm.2012.39.2.52 |
| Publication dates | |
| Published | Jun 2012 |
| File |